3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Adenocarcinoma
1
Interventions
Gemcitabine
8
Capecitabine
6
pembrolizumab
5
Carboplatin
5
Pemetrexed
3
Paclitaxel
3
Oxaliplatin
3
Irinotecan
3
regorafenib
2
osimertinib
2
Taxes
2
Sunitinib
2
Radiotherapy
2
Fluorouracil
2
Cisplatin
2
130-nm albumin-bound paclitaxel
2
trifluridine tipiracil drug combination
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
sintilimab
1
seribantumab
1
selinexor
1
ruxolitinib
1
rubitecan
1
pralsetinib
1
palbociclib
1
olaparib
1
niraparib
1
linifanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Adenocarcinoma
×
Therapeutic Irrigation
×
Clear all
NCT01476553
2017-05-02
EIPL
Universitätsmedizin Mannheim
Phase NA
Terminated
30 enrolled